01 16Gowling Lafleur Henderson LLP
02 191Merck Canada Inc.
03 34Schering-Plough Canada Inc.
01 241341567
02 102172664
03 122201749
04 42203480
05 232236591
06 102245938
07 102246162
08 232268433
09 112287056
10 232288038
11 112300452
12 142323849
13 232324467
14 232329474
15 22334267
16 142365412
17 42410662
01 28Boceprevir | Ribavirin plus Peginterferon alfa - 2b
02 6Interferon Alpha-2a
03 8Interferon Alpha-2b
04 10Interferon Alpha-2b | ribavirin
05 4Peginterferon alfa-2a
06 54Peginterferon alfa-2b
07 131Peginterferon alfa-2b | Ribavirin
01 28Capsule / Capsule / Powder for Solution for Inject
02 10Capsules and Solution for Inj.
03 65Capsules plus Powder for Solution for Injection
04 3Infectable Solution
05 54Powder for Solution for Injection
06 48Powder for Solution for Injection plus Capsule
07 12Powder for Solution for Injection pus Capsule
08 2Solution
09 4Solution
10 3Solution ;Tablets
11 3Solution;Tablets
12 3liquid
13 2powder for solution
14 4pre-filled syringe
01 122015-10-10
02 102016-03-26
03 462016-10-31
04 102017-01-21
05 42017-04-23
06 232018-04-28
07 102018-08-26
08 232018-12-16
09 502018-12-21
10 232019-03-24
11 22019-05-29
12 42021-07-19
13 242025-02-19
Patent Expiration Date : 2016-03-26
Date Granted : 2000-10-03
Brand Name : ROFERON-A
Patent Number : 2172664
Filing Date : 1996-03-26
Strength per Unit : 36.0M IU / 1ml
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Injection
Patent Expiration Date : 2016-03-26
Date Granted : 2000-10-03
Patent Expiration Date : 2016-03-26
Date Granted : 2000-10-03
Brand Name : ROFERON-A
Patent Number : 2172664
Filing Date : 1996-03-26
Strength per Unit : 9.0M IU / 0.9ml
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Injection
Patent Expiration Date : 2016-03-26
Date Granted : 2000-10-03
Patent Expiration Date : 2016-03-26
Date Granted : 2000-10-03
Brand Name : ROFERON-A
Patent Number : 2172664
Filing Date : 1996-03-26
Strength per Unit : 3.0M IU / 0.5ml
Dosage Form : pre-filled syringe
Human Or VET : Human
Route of Administration : Injection
Patent Expiration Date : 2016-03-26
Date Granted : 2000-10-03
Patent Expiration Date : 2016-03-26
Date Granted : 2000-10-03
Brand Name : ROFERON-A
Patent Number : 2172664
Filing Date : 1996-03-26
Strength per Unit : 4.5M IU / 0.5ml
Dosage Form : pre-filled syringe
Human Or VET : Human
Route of Administration : Injection
Patent Expiration Date : 2016-03-26
Date Granted : 2000-10-03
Patent Expiration Date : 2016-03-26
Date Granted : 2000-10-03
Brand Name : ROFERON-A
Patent Number : 2172664
Filing Date : 1996-03-26
Strength per Unit : 6.0M IU / 0.5ml
Dosage Form : pre-filled syringe
Human Or VET : Human
Route of Administration : Injection
Patent Expiration Date : 2016-03-26
Date Granted : 2000-10-03
Patent Expiration Date : 2016-03-26
Date Granted : 2000-10-03
Brand Name : ROFERON-A
Patent Number : 2172664
Filing Date : 1996-03-26
Strength per Unit : 9.0M IU / 0.5ml
Dosage Form : pre-filled syringe
Human Or VET : Human
Route of Administration : Injection
Patent Expiration Date : 2016-03-26
Date Granted : 2000-10-03
Patent Expiration Date : 2016-03-26
Date Granted : 2000-10-03
Brand Name : PEGASYS
Patent Number : 2172664
Filing Date : 1996-03-26
Strength per Unit : 180mcg / mL
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2016-03-26
Date Granted : 2000-10-03
Patent Expiration Date : 2016-03-26
Date Granted : 2000-10-03
Brand Name : PEGASYS
Patent Number : 2172664
Filing Date : 1996-03-26
Strength per Unit : 180mcg / 0.5mL
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2016-03-26
Date Granted : 2000-10-03
Patent Expiration Date : 2016-03-26
Date Granted : 2000-10-03
Peginterferon alfa-2b, Ribavirin
Brand Name : PEGASYS RBV
Patent Number : 2172664
Filing Date : 1996-03-26
Strength per Unit : 180 mcg / 0.5 mL; 200 mg
Dosage Form : Solution ;Tablets
Human Or VET : Human
Route of Administration : Subcutaneous and Oral
Patent Expiration Date : 2016-03-26
Date Granted : 2000-10-03
Patent Expiration Date : 2016-03-26
Date Granted : 2000-10-03
Peginterferon alfa-2b, Ribavirin
Brand Name : PEGASYS RBV
Patent Number : 2172664
Filing Date : 1996-03-26
Strength per Unit : 180 mcg / mL / vial; 200 mg
Dosage Form : Solution;Tablets
Human Or VET : Human
Route of Administration : Subcutaneous and Oral
Patent Expiration Date : 2016-03-26
Date Granted : 2000-10-03
